CCL2 and Parkinson disease: In a recent meta-analysis, CSF TGF-ß, MCP-1, and YKL-40 levels were significantly elevated in patients with neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis [41].